UA93522C2 - 2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones - Google Patents
2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-onesInfo
- Publication number
- UA93522C2 UA93522C2 UAA200805390A UAA200805390A UA93522C2 UA 93522 C2 UA93522 C2 UA 93522C2 UA A200805390 A UAA200805390 A UA A200805390A UA A200805390 A UAA200805390 A UA A200805390A UA 93522 C2 UA93522 C2 UA 93522C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pyrido
- pyrimidin
- dihydro
- amino
- compounds
- Prior art date
Links
- CZOQBGHFZWUWPV-UHFFFAOYSA-N 2-amino-7,8-dihydro-6h-pyrido[4,3-d]pyrimidin-5-one Chemical class O=C1NCCC2=NC(N)=NC=C21 CZOQBGHFZWUWPV-UHFFFAOYSA-N 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- 208000023345 Autoimmune Diseases of the Nervous System Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 208000035362 autoimmune disorder of the nervous system Diseases 0.000 abstract 1
- 208000015606 cardiovascular system disease Diseases 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72279605P | 2005-09-30 | 2005-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA93522C2 true UA93522C2 (en) | 2011-02-25 |
Family
ID=40059303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200805390A UA93522C2 (en) | 2005-09-30 | 2006-09-28 | 2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones |
Country Status (6)
| Country | Link |
|---|---|
| CN (1) | CN101287734B (es) |
| AR (1) | AR110068A2 (es) |
| SI (1) | SI1928875T1 (es) |
| SV (1) | SV2008002856A (es) |
| UA (1) | UA93522C2 (es) |
| ZA (1) | ZA200803658B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012503619A (ja) * | 2008-09-26 | 2012-02-09 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Hcv感染に対する抗ウイルス治療のための標的としての宿主細胞キナーゼ |
| CN105727297A (zh) * | 2008-11-28 | 2016-07-06 | 诺华股份有限公司 | 包含hsp90抑制剂和mtor抑制剂的药物组合 |
| AU2009319050B2 (en) * | 2008-11-28 | 2014-01-30 | Novartis Ag | Pharmaceutical combinations comprising a pyrido [4, 3-d] pyrimidine derived Hsp90-inhibitor and a HER2 inhibitor |
| EP3292120B1 (en) * | 2015-05-04 | 2019-06-19 | H. Hoffnabb-La Roche Ag | Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of hbsag (hbv surface antigen) and hbv dna production for the treatment of hepatitis b virus infections |
| CN119143631A (zh) * | 2018-11-30 | 2024-12-17 | 中外制药株式会社 | 用于肽化合物或酰胺化合物的脱保护方法和在固相反应中的树脂脱除方法以及用于生产肽化合物的方法 |
| CN109846886A (zh) * | 2019-03-26 | 2019-06-07 | 中国医学科学院基础医学研究所 | Nvp-hsp990在制备治疗癫痫的药物中的用途 |
| JP7658971B2 (ja) * | 2020-06-26 | 2025-04-08 | 日本農薬株式会社 | アリールテトラヒドロピリジン誘導体又はその塩類及び該化合物を含有する殺虫剤並びにその使用方法 |
| CN114681463B (zh) * | 2022-04-29 | 2024-03-15 | 暨南大学 | Hsp990在制备预防和/或治疗腺病毒感染的药物中的应用 |
| WO2024250985A1 (zh) * | 2023-06-07 | 2024-12-12 | 上海维申医药有限公司 | Toll样受体激动剂杂环类衍生物及其制备和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6165873A (ja) * | 1984-09-07 | 1986-04-04 | Mitsui Petrochem Ind Ltd | 2−ピペラジノピリミジン誘導体 |
| CA1307786C (en) * | 1984-12-14 | 1992-09-22 | Keiichi Yokoyama | Quinazoline derivatives and antihypertensive preparations containing same as effective components |
| IL85347A0 (en) * | 1987-02-11 | 1988-07-31 | May & Baker Ltd | Cyclic diones |
-
2006
- 2006-09-28 SI SI200631090T patent/SI1928875T1/sl unknown
- 2006-09-28 UA UAA200805390A patent/UA93522C2/ru unknown
- 2006-09-28 CN CN2006800365004A patent/CN101287734B/zh not_active Expired - Fee Related
-
2008
- 2008-03-28 SV SV2008002856A patent/SV2008002856A/es active IP Right Grant
- 2008-04-25 ZA ZA200803658A patent/ZA200803658B/xx unknown
-
2017
- 2017-11-13 AR ARP170103158A patent/AR110068A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI1928875T1 (sl) | 2011-10-28 |
| SV2008002856A (es) | 2008-06-30 |
| CN101287734A (zh) | 2008-10-15 |
| CN101287734B (zh) | 2011-07-20 |
| AR110068A2 (es) | 2019-02-20 |
| ZA200803658B (en) | 2009-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN08143A1 (en) | 2-amino-7,8-dihydro-6h-pyrido[4,3-d]pyrimidin-5-ones | |
| TW200503719A (en) | Pyridino [1,2-a] pyrimidin-4-one compounds as anticancer agents | |
| IL175714A0 (en) | Quinazolinone compounds as anticancer agents | |
| WO2005070930A3 (en) | Tetrahydrocarboline compounds as anticancer agents | |
| TW200718689A (en) | 2-Amino-quinazolin-5-ones | |
| MX2009002995A (es) | Derivados de pirazolo-[1,5-a]-pirimidina y su uso terapeutico. | |
| TW200505454A (en) | Heteroaryl-fused pyrimidinyl compounds as anticancer agents | |
| TW200626599A (en) | CRF receptor antagonists and methods relating thereto | |
| WO2008009076A3 (en) | Substituted pyrido(3,2-d)pyrimidines and pharmaceutical compositions for treating viral infections | |
| CA2603830A1 (en) | PYRIDINE [2,3-B] PYRAZINONES | |
| MX370814B (es) | Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas. | |
| PL2155758T3 (pl) | Pochodne tetrahydrofuro[3,4-d]dioksolanu przeznaczone do stosowania w leczeniu infekcji wirusowych i raka | |
| TNSN08059A1 (en) | Novel crystalline form of a pyridazino [4,5-b] indole derivative | |
| IL191751A0 (en) | Pyrrolo[2,3-c]pyridine derivatives | |
| IL191763A0 (en) | Pyrrolo [2,3-b]pyridine derivatives as h3 receptor modulators | |
| TNSN07440A1 (en) | Derivatives of pyrido [2,3 -d] pyrimidine, the preparation thereof, and the therapeutic application of the same | |
| GEP20105095B (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents | |
| SV2008002856A (es) | 2-amino-7, 8-dihidro-6h-pirido [4,3-d] pirimidina-5-onas | |
| TW200806301A (en) | Combination therapy of (2R,Z)-2-amino-2-cyclohexyl-N-(5-(1-methyl-1H-pyrazol-4-YL)-1-OXO-2,6-dihydro-1H-[1,2]diazepino[4,5,6-CD]indol-8-YL)acetamide | |
| ZA201000581B (en) | 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof | |
| ZA200900165B (en) | 4-amino-3-arylamino-6-arylpyrazolo[3,4-D]pyrimidine derivatives, methods for their preparation and their use as antiviral agents | |
| MX2009006346A (es) | Derivados de 8-etinilxantina como antagonistas de receptores de a2a selectivos. | |
| UY31020A1 (es) | 2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidina-5-onas | |
| CL2008001974A1 (es) | Compuestos derivados de ciclopenta[d]pirimidina inhibidores de la quinasa akt; proceso de preparacion; kit farmaceutico; composicion farmaceutica y uso en el tratamiento de enfermedades inflamatorias, hiperproliferativas, cardiovasculares, neurode genarativas, entre otras. | |
| UA99112C2 (en) | Use of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydr0-2h-pyrimidin-1-ylmethyl]-4-fluorobenzonitrile |